InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
8
Disclosed sells
1
T+90 hit rate
43%
T+90 mean return
-2.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hutson Nancy J, Director. Officer active across 5 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 25 filings have been recorded. Breakdown: 8 buys · 1 sell. Total volume traded: €179k. History available since 28 May 2021. The latest transaction was disclosed on 13 December 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
7,000 shares@ US$7.5418.2% of flowCommon StockSEC:0001127602-24-029494:0
6,820 shares0Common StockSEC:0001127602-24-018720:0
5,000 shares@ US$6.3810.6% of flowCommon StockSEC:0001127602-24-016190:0
Ideal exit: 14 Feb 2025 (T+270)
10,000 shares@ US$0.865.1% of flowCommon StockSEC:0001209191-23-052027:0
Ideal exit: 29 Jun 2024 (T+270)
16,745 shares0Common StockSEC:0001127602-23-018775:0
3,750 sharesCommon StockSEC:0001169245-23-000027:0
30,000 shares@ US$1.3323.8% of flowCommon StockSEC:0001209191-22-058025:0
Ideal exit: 14 Aug 2023 (T+270)
12,866 shares0Common StockSEC:0001127602-22-017163:0
3,000 shares@ US$3.086.5% of flowCommon StockSEC:0001169245-22-000067:0
Ideal exit: 15 May 2022 (T+270)
24,860 shares@ US$2.2640.2% of flowCommon StockSEC:0001169245-21-000106:0
24,860 shares@ US$2.2640.2% of flowCommon StockSEC:0001169245-21-000106
25,000 shares@ US$2.000.059% mcap37.4% of flowCommon StockSEC:0001209191-21-062427:0
25,000 shares@ US$2.0026.6% of flowCommon StockSEC:0001209191-21-062427
30,000 shares@ US$2.910.0045% mcap38.1% of flowCommon StockSEC:0001127602-21-027342:0
30,000 shares@ US$2.9127.1% of flowCommon StockSEC:0001127602-21-027342
3,000 shares@ US$3.086.5% of flowCommon StockSEC:0001169245-21-000083
Ideal exit: 15 May 2022 (T+270)
3,000 shares@ US$3.086.5% of flowCommon StockSEC:0001169245-21-000083:0
Ideal exit: 15 May 2022 (T+270)
3,000 shares@ US$5.680.020% mcap12.6% of flowCommon StockSEC:0001209191-21-051883:0
Ideal exit: 13 May 2022 (T+270)
3,000 shares@ US$5.689.0% of flowCommon StockSEC:0001209191-21-051883
Ideal exit: 13 May 2022 (T+270)
47,924 shares0Ordinary SharesSEC:0001593034-21-000079
47,924 shares0Ordinary SharesSEC:0001593034-21-000079:0
8,333 shares@ US$2.857.0% of flowCommon StockSEC:0001127602-21-019792
8,333 shares@ US$2.850.0012% mcap9.9% of flowCommon StockSEC:0001127602-21-019792:0
317 shares@ US$15.772.1% of flowCommon StockSEC:0001127602-21-018492
317 shares@ US$15.770.0002% mcap2.1% of flowCommon StockSEC:0001127602-21-018492:0
25 of 25 declarations
About Hutson Nancy J
Nancy J Hutson is associated with BIOCRYST PHARMACEUTICALS INC.
